<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Weight loss outcomes with FDA-approved medications</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Weight loss outcomes with FDA-approved medications</h1>
<div class="graphic"><div class="figure"><div class="ttl">Weight loss outcomes with FDA-approved medications</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Weight loss reflects results at 52 weeks, except for semaglutide and liraglutide, which reflect weight loss at 68 weeks.</div><div class="graphic_footnotes">FDA: US Food and Drug Administration.</div><div class="graphic_reference">Courtesy of George A Bray, MD.<br/>
Data from:
<ol>
<li>Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: A systematic review and meta-analysis. JAMA 2016; 315:2424.</li>
<li>Rubino DM, Greenway FL, Khalid U, et al. Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA 2022; 327:138.</li>
<li>Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384:989.</li>
</ol></div><div id="graphicVersion">Graphic 115096 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
